Adlai Nortye Group Ltd. key statistics and ratios
In fiscal 2025, Adlai Nortye Group Ltd. had return on equity of -106.5%, an operating margin of -714.0% and a current ratio of 0.65. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2021Dec 2021 | 2023Dec 2023 | 2025Dec 2025 |
|---|---|---|---|
| Operating margin | −18.9% | <−999% | −714.0% |
| Net margin | −124.0% | <−999% | −710.6% |
| Free-cash-flow margin | −8.9% | <−999% | −672.8% |
| Return on equity | — | — | −106.5% |
| Return on assets | — | −83.9% | −43.2% |
| Asset turnover | — | 0.04 | 0.06 |
| Current ratio | — | 2.04 | 0.65 |
| Debt to equity | — | 40.5% | — |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m |
| R&D as % of revenue | 92.1% | >999% | 656.7% |
| Capital spending as % of revenue | 2.2% | 4.0% | 3.7% |
Financial health
- Short-term assets cover short-term liabilities $27m of assets due within a year against $42m of liabilities due within a year.
- Short-term assets cover long-term liabilities $27m short-term assets against $1m of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Operating income of −$36m against $42,000 of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Inventiva S.a. statistics
- Rani Therapeutics Holdings, Inc. statistics
- Immuron Ltd statistics
- Bolt Biotherapeutics, Inc. statistics
- Entrada Therapeutics, Inc. statistics
Head to head: ANL vs IVAANL vs RANIANL vs IMRN
More: Biotechnology stocks compared, Health Care sector, rankings of US companies